Hello and Welcome to Patientsville.com, Your Source for all UROFOLLITROPIN information. We are dedicated to provide You with UROFOLLITROPIN safety information. Learn about UROFOLLITROPIN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
UROFOLLITROPIN Safety Reports
Total UROFOLLITROPIN reports: 2.UROFOLLITROPIN FDA safety alerts: No.
Reported hospitalizations: 1.
Take UROFOLLITROPIN Side Effects Survey or Share Your UROFOLLITROPIN Story. Read More Here.
Consumer or non-health professional from JAPAN reported UROFOLLITROPIN problem on May 02, 2007. Female patient, 32 years of age, was diagnosed with assisted fertilisation and was treated with UROFOLLITROPIN. After drug was administered, patient experienced the following problems/side effects: haemoconcentration, hypovolaemic shock, obstetric procedure complication, ovarian hyperstimulation syndrome, pleural effusion, polycystic ovaries, respiratory failure. UROFOLLITROPIN dosage: unknown. During the same period patient was treated with CHORIONIC GONADOTROPIN. Patient was hospitalized. Patient recovered.
UROFOLLITROPIN problem was reported by a Consumer or non-health professional from JAPAN on Oct 23, 2006. Female patient, 36 years of age, was diagnosed with in vitro fertilisation and was treated with UROFOLLITROPIN. After drug was administered, patient experienced the following problems/side effects: abortion induced, multiple pregnancy. UROFOLLITROPIN dosage: unknown. During the same period patient was treated with CHORIONIC GONADTROPIN. Patient recovered.